Patent Marking

Notice is provided pursuant to 35 U.S.C. § 287(a) that the following Luye products, the process of their manufacture, and/or their use may be covered by one or more U.S. patents, including the U.S. patents identified below. This list may be a subset of the U.S. patents and/or U.S. patent applications that are directed to these products, the process of their manufacture, and/or their use.

ERZOFRI® (paliperidone palmitate)​

U.S. patent numbers 11,666,573 and 12,128,049. ​

RYKINDO® (risperidone)​

U.S. patent numbers 9,446,135; 9,532,991; 10,098,882; 10,406,161; and 11,110,094.